Clinical trial
Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients
NCT07606638 is registered in ClinicalTrials.gov with Mayo Hospital Lahore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients
- Lead sponsor
- Mayo Hospital Lahore
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- February 1, 2026
- Completion date
- July 30, 2026
- Enrollment
- 98 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oral cancer, oral cavity cancer, oral squamous cell carcinoma (oscc)